Crp C-Reactionprotein Diagnostic Kits with Ce

• Classification: Biological Diagnostics
• Type: Poct Reagent
• Certification: CE, ISO13485
• Group: All Men
• Suitable Instrument: Fia8600/ Fia8000
• Transport Package: Carton
• Model NO.: CG1003
• Specification: 25 test/Box
• Trademark: GP
• Origin: Jiangsu
• HS Code: 3002100090

Product Description

 The One Step Test for hs-CRP+CRP (colloidal gold) is intended for use together with the FIA8000 Quantitative Immunoassay Analyzer (FIA8000). The product employs colloidal gold immunochromatogrphy to determine hs-CRP+CRP in human serum, plasma, whole blood or fingertip blood specimens. Two monoclonal antibodies are employed to identify hs-CRP+CRP specifically, resulting in a purplish red streak appears on the test line. The color intensity of the test line increases in proportion to the concentrations of hs-CRP+CRP.
Then insert test card into the FIA8000 Quantitative Immunoassay Analyzer, the concentration of hs-CRP+CRP is measured quantitatively and displayed on the screen. The result can be transmitted to the lab or hospital information system.
 

Department	Clinical Application
Respiration	Respiratory tract infection ,pulmonary infection (bacterial),lung neoplasm,tuberculosis, pulmonary infarction, lung abscess, empyema
Pediatrics	Diagnosis and identification of various inflammatory or infection diseases of children and infants
Gastroenterology	Cholecystitis, liver abscess, peritonitis, malignant tumor
Urology	Pyelonephritis, endonephritis, cystitis, perinephretic Abscess, cancer etc
Gynecology	Clinical detection of normal gynecological inflammation, therapy monitoring of gynecologic surgery
Stomatology	Periodontitis, maxillofacial infection , maxillofacial injuries, implant surgery, ICU, monitoring the nosocomial infections, detection before and after tooth extraction operation
Oncology	Accessory diagnosis of malignant neoplasm, detection after chemotherapy, clinical detection before or after tumor operation
Cardiology	Detection of cardiovascular inflammatory lesion, monitoring the prognostic implications of cardiac diseases
Other departments	Collagenosis, allergic and autoimmune disease activity period (rheumatism, SLE, rheumatoid), infectious disease, sepsis and other malignancies

Company Profile


Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care, clinical chemistry, chemiluminescent assays, and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. It also manufactures analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics, pharmaceuticals, and academic research.